RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 74 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,000 | +200.0% | 1,119 | +404.1% | 0.00% | – |
| Q4 2021 | $2,000 | -50.0% | 222 | 0.0% | 0.00% | – |
| Q3 2021 | $4,000 | -20.0% | 222 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -16.7% | 222 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | +200.0% | 222 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | – | 222 | +98.2% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 112 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |